
Bryan Y. Lee
Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | IWPI, 2445, 2615 |
| Total Applications | 446 |
| Issued Applications | 316 |
| Pending Applications | 28 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5598076
[patent_doc_number] => 20060161994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Functional assays for cholesterol absorption inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/301094
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15249
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20060161994.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301094 | Functional assays for cholesterol absorption inhibitors | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5678347
[patent_doc_number] => 20060183703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Circular expression construct for gene therapeutic applications'
[patent_app_type] => utility
[patent_app_number] => 11/299327
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7758
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299327 | Circular expression construct for gene therapeutic applications | Dec 8, 2005 | Abandoned |
Array
(
[id] => 5625371
[patent_doc_number] => 20060263876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Neural crest stem cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/295370
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4160
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295370 | Neural crest stem cells and uses thereof | Dec 5, 2005 | Abandoned |
Array
(
[id] => 5655181
[patent_doc_number] => 20060140916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Methods and compositions for treating congestive heart failure'
[patent_app_type] => utility
[patent_app_number] => 11/285932
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14506
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285932
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285932 | Methods and compositions for treating congestive heart failure | Nov 21, 2005 | Abandoned |
Array
(
[id] => 5655186
[patent_doc_number] => 20060140921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain'
[patent_app_type] => utility
[patent_app_number] => 11/253731
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140921.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253731
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253731 | Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain | Oct 19, 2005 | Abandoned |
Array
(
[id] => 307288
[patent_doc_number] => 07531354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Neuronal progenitors from feeder-free human embryonic stem cell culture'
[patent_app_type] => utility
[patent_app_number] => 11/243819
[patent_app_country] => US
[patent_app_date] => 2005-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13987
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531354.pdf
[firstpage_image] =>[orig_patent_app_number] => 11243819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/243819 | Neuronal progenitors from feeder-free human embryonic stem cell culture | Oct 4, 2005 | Issued |
Array
(
[id] => 5638049
[patent_doc_number] => 20060069023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Animal model for studying hormone signalling and method of modulating the signalling'
[patent_app_type] => utility
[patent_app_number] => 11/231101
[patent_app_country] => US
[patent_app_date] => 2005-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11782
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069023.pdf
[firstpage_image] =>[orig_patent_app_number] => 11231101
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/231101 | Animal model for studying hormone signalling and method of modulating the signalling | Sep 18, 2005 | Abandoned |
Array
(
[id] => 5710520
[patent_doc_number] => 20060051865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Systems and methods for isolating stromal cells from adipose tissue and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/217087
[patent_app_country] => US
[patent_app_date] => 2005-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3218
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11217087
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/217087 | Systems and methods for isolating stromal cells from adipose tissue and uses thereof | Aug 30, 2005 | Abandoned |
Array
(
[id] => 5657983
[patent_doc_number] => 20060143719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Use of golden hamster as infectivity model of SARS'
[patent_app_type] => utility
[patent_app_number] => 11/204393
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3690
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20060143719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11204393
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/204393 | Use of golden hamster as infectivity model of SARS | Aug 15, 2005 | Abandoned |
Array
(
[id] => 4713295
[patent_doc_number] => 20080301821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Diagnostic and Therapeutic use of a Plasma Membrane Atpase'
[patent_app_type] => utility
[patent_app_number] => 11/659853
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16759
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20080301821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659853 | Diagnostic and Therapeutic use of a Plasma Membrane Atpase | Aug 7, 2005 | Abandoned |
Array
(
[id] => 5242868
[patent_doc_number] => 20070021363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Genomic replacement therapy'
[patent_app_type] => utility
[patent_app_number] => 11/186885
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186885 | Genomic replacement therapy | Jul 21, 2005 | Abandoned |
Array
(
[id] => 5011977
[patent_doc_number] => 20070282456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Compositions and Methods for Myogenesis of Fat-Derived Stem Cells Expressing Telomerase and Myocardin'
[patent_app_type] => utility
[patent_app_number] => 11/571985
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7601
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20070282456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571985
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571985 | Compositions and Methods for Myogenesis of Fat-Derived Stem Cells Expressing Telomerase and Myocardin | Jul 12, 2005 | Abandoned |
Array
(
[id] => 5794261
[patent_doc_number] => 20060014942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Nucleotide sequences for the control of the expression of DNA sequences in a cell host'
[patent_app_type] => utility
[patent_app_number] => 11/174485
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13397
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11174485
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/174485 | Nucleotide sequences for the control of the expression of DNA sequences in a cell host | Jul 5, 2005 | Abandoned |
Array
(
[id] => 6932183
[patent_doc_number] => 20050283218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Implantable chamber for biological induction or enhancement of muscle contraction'
[patent_app_type] => utility
[patent_app_number] => 11/150374
[patent_app_country] => US
[patent_app_date] => 2005-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6969
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0283/20050283218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11150374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/150374 | Implantable chamber for biological induction or enhancement of muscle contraction | Jun 10, 2005 | Abandoned |
Array
(
[id] => 5712154
[patent_doc_number] => 20060053500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Modification of sugar metabolic processes in transgenic cells, tissues and animals'
[patent_app_type] => utility
[patent_app_number] => 11/141611
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 44183
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20060053500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11141611
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/141611 | Modification of sugar metabolic processes in transgenic cells, tissues and animals | May 30, 2005 | Abandoned |
Array
(
[id] => 5771368
[patent_doc_number] => 20060021074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Reducing the risk of human anti-human antibodies through V gene manipulation'
[patent_app_type] => utility
[patent_app_number] => 11/136250
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 43744
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20060021074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11136250
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/136250 | Determining the risk of human anti-human antibodies in transgenic mice | May 22, 2005 | Issued |
Array
(
[id] => 4579867
[patent_doc_number] => 07850957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells'
[patent_app_type] => utility
[patent_app_number] => 11/569303
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 10338
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/850/07850957.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569303 | Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells | May 17, 2005 | Issued |
Array
(
[id] => 5822384
[patent_doc_number] => 20060026697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Genetic immunization of transgenic animals with non-eukaryotic expression systems'
[patent_app_type] => utility
[patent_app_number] => 11/132165
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22806
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20060026697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132165
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132165 | Genetic immunization of transgenic animals with non-eukaryotic expression systems | May 17, 2005 | Abandoned |
Array
(
[id] => 5766982
[patent_doc_number] => 20060018971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Nucleic acid microspheres, production and delivery thereof'
[patent_app_type] => utility
[patent_app_number] => 11/127362
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6823
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018971.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127362 | Nucleic acid microspheres, production and delivery thereof | May 11, 2005 | Issued |
Array
(
[id] => 42828
[patent_doc_number] => 07776322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Modified viral vector particles'
[patent_app_type] => utility
[patent_app_number] => 11/120155
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12549
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120155 | Modified viral vector particles | May 1, 2005 | Issued |